drugset / Trial / NCT00727493

Osteoporosis and Dental Implant

NCT00727493

Phase 4 Unknown 45 enrolled Charite University, Berlin, Germany
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the influence of alendronate therapy on the wound healing after dental implants in patients with osteoporosis.

Timeline

Start
2004-01
Primary completion
2010-01
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alendronic Acid Small molecule 70 mg

Indications